LECAP Asset Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Sell
1,337
-3,685
-73% -$1.55M 0.27% 152
2026
Q1
$1.9M Buy
5,022
+2,911
+138% +$1.25M 0.71% 31
2025
Q4
$903K Buy
+2,111
New +$919K 0.36% 109
2025
Q3
Sell
-2,009
Closed -$978K 295
2025
Q2
$978K Buy
+2,009
New +$1.14M 0.35% 114
2025
Q1
Sell
-2,133
Closed -$1.13M 303
2024
Q4
$1.13M Buy
+2,133
New +$1.2M 0.31% 135
2024
Q3
Sell
-1,609
Closed -$873K 320
2024
Q2
$873K Buy
+1,609
New +$922K 0.19% 188

Other funds holding CHE

LECAP Asset Management's CHE Position: Q2 2026 in Review

LECAP Asset Management reduced its Chemed (CHE) stake by 73% in Q2 2026, selling an estimated $1.55M and leaving 1,337 shares worth $623K. The position accounts for 0.27% of the portfolio, ranked #152.

LECAP Asset Management first reported a position in CHE in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.9M in Q1 2026. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • LECAP Asset Management held 1,337 shares of Chemed worth $623K as of Q2 2026.
  • LECAP Asset Management sold 3,685 Chemed shares in Q2 2026, an estimated $1.55M.
  • Chemed made up 0.27% of LECAP Asset Management's portfolio in Q2 2026, its #152 holding.
  • LECAP Asset Management first reported a position in Chemed in Q2 2024 and has held it in 6 quarters since.
  • LECAP Asset Management's Chemed position peaked at $1.9M in Q1 2026.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.